Trademark Filing
Mission Pharmacal Company
| Serial Number | 86064472 |
| Registration Number | 4485359 |
| Mark Drawing Code | 2000: Illustration: Drawing or design without any word(s)/letter(s)/ number(s) |
| Attorney Name | Pamela B. Huff |
| Attorney Docket Number | 4825.101US2 |
| Law Office Assigned | M80 |
| Employee Name | HOWARD, PARKER WALDRIP |
Timeline
| 1984-05-31 | Date of First Use |
| 2013-09-13 | Application Filed |
| 2013-12-03 | Published for Opposition |
| 2014-02-18 | Trademark Registered |
| 2019-04-04 | Location: TMO LAW OFFICE 117 |
| 2019-04-04 | Status: Live/Registered |
| 2019-04-04 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Mission Pharmacal Company |
| Address | 10999 IH 10 West, Suite 1000 San Antonio TX 78230 |
| Legal Entity Type | Corporation |
| Legal Entity State | TX |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 170502 | Scales of Justice; Scales, two pan balance scales; Weights, weights for scales |
| 260921 | Squares that are completely or partially shaded |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical preparations for use in treating allergic and dermatologic disorders, namely, a topically applied acne treatment; pharmaceutical ointment used for the prevention and treatment of rash; pharmaceutical preparations for use in the treatment and prevention of skin disorders; analgesic balm; sodium salt tablets for use in the treatment of low blood level sodium; prenatal multi-vitamins and multi-minerals; dietary supplements inclusive of calcium salt; dietary supplements consisting primarily of calcium fluoride; prophylactic drug preventing calcium absorption by the human body; preparation for prevention and relief of complications of pregnancy and lactation resulting from inadequate nutrition and imbalance; preparation for the treatment of secondary anemia; detoxicating agents for use as liver protective agents; drug inclusive of potassium citrate for treatment of kidney stones and the urinary tract system; surgical lubricating jelly |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2013-09-17 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2013-09-21 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2013-09-24 | 3 MDSC E:E-Mail |
| ASSIGNED TO EXAMINER | 2013-10-23 | 4 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2013-10-29 | 5 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2013-11-13 | 6 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2013-12-03 | 7 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2013-12-03 | 8 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2014-02-18 | 9 R.PR A:Allowance for Publication |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2017-07-07 | 10 TCCA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2019-02-18 | 11 REM1 E:E-Mail |
| TEAS SECTION 8 & 15 RECEIVED | 2019-03-04 | 12 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2019-04-04 | 13 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2019-04-04 | 14 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2019-04-04 | 15 NA85 E:E-Mail |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2023-02-18 | 16 REM2 E:E-Mail |
| TEAS SECTION 8 & 9 RECEIVED | 2024-01-26 | 17 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2024-05-14 | 18 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2024-05-14 | 19 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2024-05-14 | 20 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2024-05-14 | 21 NA89 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 